### SUBPART 3—APPLICATION TO MEDICARE ADVANTAGE PROGRAM AND TREATMENT OF EMPLOYER-SPONSORED PROGRAMS AND OTHER PRESCRIPTION DRUG PLANS

### §1395w–131. Application to Medicare Advantage program and related managed care programs
#### (a) Special rules relating to offering of qualified prescription drug coverage
* #### (1) In general
  * An MA organization on and after January 1, 2006—

    * (A) may not offer an MA plan described in section 1395w–21(a)(2)(A) of this title in an area unless either that plan (or another MA plan offered by the organization in that same service area) includes required prescription drug coverage (as defined in paragraph (2)); and

    * (B) may not offer prescription drug coverage (other than that required under parts A and B) to an enrollee—

      * (i) under an MSA plan; or

      * (ii) under another MA plan unless such drug coverage under such other plan provides qualified prescription drug coverage and unless the requirements of this section with respect to such coverage are met.

* #### (2) Qualifying coverage
  * For purposes of paragraph (1)(A), the term "required coverage" means with respect to an MA–PD plan—

    * (A) basic prescription drug coverage; or

    * (B) qualified prescription drug coverage that provides supplemental prescription drug coverage, so long as there is no MA monthly supplemental beneficiary premium applied under the plan (due to the application of a credit against such premium of a rebate under section 1395w–24(b)(1)(C) of this title).

#### (b) Application of default enrollment rules
* #### (1) Seamless continuation
  * In applying section 1395w–21(c)(3)(A)(ii) of this title, an individual who is enrolled in a health benefits plan shall not be considered to have been deemed to make an election into an MA–PD plan unless such health benefits plan provides any prescription drug coverage.

* #### (2) MA continuation
  * In applying section 1395w–21(c)(3)(B) of this title, an individual who is enrolled in an MA plan shall not be considered to have been deemed to make an election into an MA–PD plan unless—

    * (A) for purposes of the election as of January 1, 2006, the MA plan provided as of December 31, 2005, any prescription drug coverage; or

    * (B) for periods after January 1, 2006, such MA plan is an MA–PD plan.

* #### (3) Discontinuance of MA–PD election during first year of eligibility
  * In applying the second sentence of section 1395w–21(e)(4) of this title in the case of an individual who is electing to discontinue enrollment in an MA–PD plan, the individual shall be permitted to enroll in a prescription drug plan under part D at the time of the election of coverage under the original medicare fee-for-service program.

* #### (4) Rules regarding enrollees in MA plans not providing qualified prescription drug coverage
  * In the case of an individual who is enrolled in an MA plan (other than an MSA plan) that does not provide qualified prescription drug coverage, if the organization offering such coverage discontinues the offering with respect to the individual of all MA plans that do not provide such coverage—

    * (i) the individual is deemed to have elected the original medicare fee-for-service program option, unless the individual affirmatively elects to enroll in an MA–PD plan; and

    * (ii) in the case of such a deemed election, the disenrollment shall be treated as an involuntary termination of the MA plan described in subparagraph (B)(ii) of section 1395ss(s)(3) of this title for purposes of applying such section.


* The information disclosed under section 1395w–22(c)(1) of this title for individuals who are enrolled in such an MA plan shall include information regarding such rules.

#### (c) Application of part D rules for prescription drug coverage
* With respect to the offering of qualified prescription drug coverage by an MA organization under this part on and after January 1, 2006—

* #### (1) In general
  * Except as otherwise provided, the provisions of this part shall apply under part C with respect to prescription drug coverage provided under MA–PD plans in lieu of the other provisions of part C that would apply to such coverage under such plans.

* #### (2) Waiver
  * The Secretary shall waive the provisions referred to in paragraph (1) to the extent the Secretary determines that such provisions duplicate, or are in conflict with, provisions otherwise applicable to the organization or plan under part C or as may be necessary in order to improve coordination of this part with the benefits under this part.

* #### (3) Treatment of MA owned and operated pharmacies
  * The Secretary may waive the requirement of section 1395w–104(b)(1)(C) of this title in the case of an MA–PD plan that provides access (other than mail order) to qualified prescription drug coverage through pharmacies owned and operated by the MA organization, if the Secretary determines that the organization's pharmacy network is sufficient to provide comparable access for enrollees under the plan.

#### (d) Special rules for private fee-for-service plans that offer prescription drug coverage
* With respect to an MA plan described in section 1395w–21(a)(2)(C) of this title that offers qualified prescription drug coverage, on and after January 1, 2006, the following rules apply:

* #### (1) Requirements regarding negotiated prices
  * Subsections (a)(1) and (d)(1) of section 1395w–102 of this title and section 1395w–104(b)(2)(A) of this title shall not be construed to require the plan to provide negotiated prices (described in subsection (d)(1)(B) of such section), but shall apply to the extent the plan does so.

* #### (2) Modification of pharmacy access standard and disclosure requirement
  * If the plan provides coverage for drugs purchased from all pharmacies, without charging additional cost-sharing, and without regard to whether they are participating pharmacies in a network or have entered into contracts or agreements with pharmacies to provide drugs to enrollees covered by the plan, subsections (b)(1)(C) and (k) of section 1395w–104 of this title shall not apply to the plan.

* #### (3) Drug utilization management program and medication therapy management program not required
  * The requirements of subparagraphs (A) and (C) of section 1395w–104(c)(1) of this title shall not apply to the plan.

* #### (4) Application of reinsurance
  * The Secretary shall determine the amount of reinsurance payments under section 1395w–115(b) of this title using a methodology that—

    * (A) bases such amount on the Secretary's estimate of the amount of such payments that would be payable if the plan were an MA–PD plan described in section 1395w–21(a)(2)(A)(i) of this title and the previous provisions of this subsection did not apply; and

    * (B) takes into account the average reinsurance payments made under section 1395w–115(b) of this title for populations of similar risk under MA–PD plans described in such section.

* #### (5) Exemption from risk corridor provisions
  * The provisions of section 1395w–115(e) of this title shall not apply.

* #### (6) Exemption from negotiations
  * Subsections (d) and (e)(2)(C) of section 1395w–111 of this title shall not apply and the provisions of section 1395w–24(a)(5)(B) of this title prohibiting the review, approval, or disapproval of amounts described in such section shall apply to the proposed bid and terms and conditions described in section 1395w–111(d) of this title.

* #### (7) Treatment of incurred costs without regard to formulary
  * The exclusion of costs incurred for covered part D drugs which are not included (or treated as being included) in a plan's formulary under section 1395w–102(b)(4)(B)(i) of this title shall not apply insofar as the plan does not utilize a formulary.

#### (e) Application to reasonable cost reimbursement contractors
* #### (1) In general
  * Subject to paragraphs (2) and (3) and rules established by the Secretary, in the case of an organization that is providing benefits under a reasonable cost reimbursement contract under section 1395mm(h) of this title and that elects to provide qualified prescription drug coverage to a part D eligible individual who is enrolled under such a contract, the provisions of this part (and related provisions of part C) shall apply to the provision of such coverage to such enrollee in the same manner as such provisions apply to the provision of such coverage under an MA–PD local plan described in section 1395–21(a)(2)(A)(i) of this title and coverage under such a contract that so provides qualified prescription drug coverage shall be deemed to be an MA–PD local plan.

* #### (2) Limitation on enrollment
  * In applying paragraph (1), the organization may not enroll part D eligible individuals who are not enrolled under the reasonable cost reimbursement contract involved.

* #### (3) Bids not included in determining national average monthly bid amount
  * The bid of an organization offering prescription drug coverage under this subsection shall not be taken into account in computing the national average monthly bid amount and low-income benchmark premium amount under this part.

#### (f) Application to PACE
* #### (1) In general
  * Subject to paragraphs (2) and (3) and rules established by the Secretary, in the case of a PACE program under section 1395eee of this title that elects to provide qualified prescription drug coverage to a part D eligible individual who is enrolled under such program, the provisions of this part (and related provisions of part C) shall apply to the provision of such coverage to such enrollee in a manner that is similar to the manner in which such provisions apply to the provision of such coverage under an MA–PD local plan described in section 1395w–21(a)(2)(A)(ii) of this title and a PACE program that so provides such coverage may be deemed to be an MA–PD local plan.

* #### (2) Limitation on enrollment
  * In applying paragraph (1), the organization may not enroll part D eligible individuals who are not enrolled under the PACE program involved.

* #### (3) Bids not included in determining standardized bid amount
  * The bid of an organization offering prescription drug coverage under this subsection is not be taken into account in computing any average benchmark bid amount and low-income benchmark premium amount under this part.

### §1395w–132. Special rules for employer-sponsored programs
#### (a) Subsidy payment
* #### (1) In general
  * The Secretary shall provide in accordance with this subsection for payment to the sponsor of a qualified retiree prescription drug plan (as defined in paragraph (2)) of a special subsidy payment equal to the amount specified in paragraph (3) for each qualified covered retiree under the plan (as defined in paragraph (4)). This subsection constitutes budget authority in advance of appropriations Acts and represents the obligation of the Secretary to provide for the payment of amounts provided under this section.

* #### (2) Qualified retiree prescription drug plan defined
  * For purposes of this subsection, the term "qualified retiree prescription drug plan" means employment-based retiree health coverage (as defined in subsection (c)(1)) if, with respect to a part D eligible individual who is a participant or beneficiary under such coverage, the following requirements are met:

  * #### (A) Attestation of actuarial equivalence to standard coverage
    * The sponsor of the plan provides the Secretary, annually or at such other time as the Secretary may require, with an attestation that the actuarial value of prescription drug coverage under the plan (as determined using the processes and methods described in section 1395w–111(c) of this title) is at least equal to the actuarial value of standard prescription drug coverage, not taking into account the value of any discount or coverage provided during the gap in prescription drug coverage that occurs between the initial coverage limit under section 1395w–102(b)(3) of this title during the year and the out-of-pocket threshold specified in section 1395w–102(b)(4)(B) of this title.

  * #### (B) Audits
    * The sponsor of the plan, or an administrator of the plan designated by the sponsor, shall maintain (and afford the Secretary access to) such records as the Secretary may require for purposes of audits and other oversight activities necessary to ensure the adequacy of prescription drug coverage and the accuracy of payments made under this section. The provisions of section 1395w–102(d)(3) of this title shall apply to such information under this section (including such actuarial value and attestation) in a manner similar to the manner in which they apply to financial records of PDP sponsors and MA organizations.

  * #### (C) Provision of disclosure regarding prescription drug coverage
    * The sponsor of the plan shall provide for disclosure of information regarding prescription drug coverage in accordance with section 1395w–113(b)(6)(B) of this title.

* #### (3) Employer and union special subsidy amounts
  * #### (A) In general
    * For purposes of this subsection, the special subsidy payment amount under this paragraph for a qualifying covered retiree for a coverage year enrolled with the sponsor of a qualified retiree prescription drug plan is, for the portion of the retiree's gross covered retiree plan-related prescription drug costs (as defined in subparagraph (C)(ii)) for such year that exceeds the cost threshold amount specified in subparagraph (B) and does not exceed the cost limit under such subparagraph, an amount equal to 28 percent of the allowable retiree costs (as defined in subparagraph (C)(i)) attributable to such gross covered prescription drug costs.

  * #### (B) Cost threshold and cost limit applicable
    * #### (i) In general
      * Subject to clause (ii)—

        * (I) the cost threshold under this subparagraph is equal to $250 for plan years that end in 2006; and

        * (II) the cost limit under this subparagraph is equal to $5,000 for plan years that end in 2006.

    * #### (ii) Indexing
      * The cost threshold and cost limit amounts specified in subclauses (I) and (II) of clause (i) for a plan year that ends after 2006 shall be adjusted in the same manner as the annual deductible and the annual out-of-pocket threshold, respectively, are annually adjusted under paragraphs (1) and (4)(B) of section 1395w–102(b) of this title.

  * #### (C) Definitions
    * For purposes of this paragraph:

    * #### (i) Allowable retiree costs
      * The term "allowable retiree costs" means, with respect to gross covered prescription drug costs under a qualified retiree prescription drug plan by a plan sponsor, the part of such costs that are actually paid (net of discounts, chargebacks, and average percentage rebates) by the sponsor or by or on behalf of a qualifying covered retiree under the plan.

    * #### (ii) Gross covered retiree plan-related prescription drug costs
      * For purposes of this section, the term "gross covered retiree plan-related prescription drug costs" means, with respect to a qualifying covered retiree enrolled in a qualified retiree prescription drug plan during a coverage year, the costs incurred under the plan, not including administrative costs, but including costs directly related to the dispensing of covered part D drugs during the year. Such costs shall be determined whether they are paid by the retiree or under the plan.

    * #### (iii) Coverage year
      * The term "coverage year" has the meaning given such term in section 1395w–115(b)(4) of this title.

* #### (4) Qualifying covered retiree defined
  * For purposes of this subsection, the term "qualifying covered retiree" means a part D eligible individual who is not enrolled in a prescription drug plan or an MA–PD plan but is covered under a qualified retiree prescription drug plan.

* #### (5) Payment methods, including provision of necessary information
  * The provisions of section 1395w–115(d) of this title (including paragraph (2), relating to requirement for provision of information) shall apply to payments under this subsection in a manner similar to the manner in which they apply to payment under section 1395w–115(b) of this title.

* #### (6) Construction
  * Nothing in this subsection shall be construed as—

    * (A) precluding a part D eligible individual who is covered under employment-based retiree health coverage from enrolling in a prescription drug plan or in an MA–PD plan;

    * (B) precluding such employment-based retiree health coverage or an employer or other person from paying all or any portion of any premium required for coverage under a prescription drug plan or MA–PD plan on behalf of such an individual;

    * (C) preventing such employment-based retiree health coverage from providing coverage—

      * (i) that is better than standard prescription drug coverage to retirees who are covered under a qualified retiree prescription drug plan; or

      * (ii) that is supplemental to the benefits provided under a prescription drug plan or an MA–PD plan, including benefits to retirees who are not covered under a qualified retiree prescription drug plan but who are enrolled in such a prescription drug plan or MA–PD plan; or


    * (D) preventing employers to provide for flexibility in benefit design and pharmacy access provisions, without regard to the requirements for basic prescription drug coverage, so long as the actuarial equivalence requirement of paragraph (2)(A) is met.

#### (b) Application of MA waiver authority
* The provisions of section 1395w–27(i) of this title shall apply with respect to prescription drug plans in relation to employment-based retiree health coverage in a manner similar to the manner in which they apply to an MA plan in relation to employers, including authorizing the establishment of separate premium amounts for enrollees in a prescription drug plan by reason of such coverage and limitations on enrollment to part D eligible individuals enrolled under such coverage.

#### (c) Definitions
* For purposes of this section:

* #### (1) Employment-based retiree health coverage
  * The term "employment-based retiree health coverage" means health insurance or other coverage of health care costs (whether provided by voluntary insurance coverage or pursuant to statutory or contractual obligation) for part D eligible individuals (or for such individuals and their spouses and dependents) under a group health plan based on their status as retired participants in such plan.

* #### (2) Sponsor
  * The term "sponsor" means a plan sponsor, as defined in section 1002(16)(B) of title 29, in relation to a group health plan, except that, in the case of a plan maintained jointly by one employer and an employee organization and with respect to which the employer is the primary source of financing, such term means such employer.

* #### (3) Group health plan
  * The term "group health plan" includes such a plan as defined in section 1167(1) of title 29 and also includes the following:

  * #### (A) Federal and State governmental plans
    * Such a plan established or maintained for its employees by the Government of the United States, by the government of any State or political subdivision thereof, or by any agency or instrumentality of any of the foregoing, including a health benefits plan offered under chapter 89 of title 5.

  * #### (B) Collectively bargained plans
    * Such a plan established or maintained under or pursuant to one or more collective bargaining agreements.

  * #### (C) Church plans
    * Such a plan established and maintained for its employees (or their beneficiaries) by a church or by a convention or association of churches which is exempt from tax under section 501 of the Internal Revenue Code of 1986.

### §1395w–133. State Pharmaceutical Assistance Programs
#### (a) Requirements for benefit coordination
* #### (1) In general
  * Before July 1, 2005, the Secretary shall establish consistent with this section requirements for prescription drug plans to ensure the effective coordination between a part D plan (as defined in paragraph (5)) and a State Pharmaceutical Assistance Program (as defined in subsection (b)) with respect to—

    * (A) payment of premiums and coverage; and

    * (B) payment for supplemental prescription drug benefits,


* for part D eligible individuals enrolled under both types of plans.

* #### (2) Coordination elements
  * The requirements under paragraph (1) shall include requirements relating to coordination of each of the following:

    * (A) Enrollment file sharing.

    * (B) The processing of claims, including electronic processing.

    * (C) Claims payment.

    * (D) Claims reconciliation reports.

    * (E) Application of the protection against high out-of-pocket expenditures under section 1395w–102(b)(4) of this title.

    * (F) Other administrative processes specified by the Secretary.


* Such requirements shall be consistent with applicable law to safeguard the privacy of any individually identifiable beneficiary information.

* #### (3) Use of lump sum per capita method
  * Such requirements shall include a method for the application by a part D plan of specified funding amounts from a State Pharmaceutical Assistance Program for enrolled individuals for supplemental prescription drug benefits.

* #### (4) Consultation
  * In establishing requirements under this subsection, the Secretary shall consult with State Pharmaceutical Assistance Programs, MA organizations, States, pharmaceutical benefit managers, employers, representatives of part D eligible individuals, the data processing experts, pharmacists, pharmaceutical manufacturers, and other experts.

* #### (5) Part D plan defined
  * For purposes of this section and section 1395w–134 of this title, the term "part D plan" means a prescription drug plan and an MA–PD plan.

#### (b) State Pharmaceutical Assistance Program
* For purposes of this part, the term "State Pharmaceutical Assistance Program" means a State program—

  * (1) which provides financial assistance for the purchase or provision of supplemental prescription drug coverage or benefits on behalf of part D eligible individuals;

  * (2) which, in determining eligibility and the amount of assistance to part D eligible individuals under the Program, provides assistance to such individuals in all part D plans and does not discriminate based upon the part D plan in which the individual is enrolled; and

  * (3) which satisfies the requirements of subsections (a) and (c).

#### (c) Relation to other provisions
* #### (1) Medicare as primary payor
  * The requirements of this section shall not change or affect the primary payor status of a part D plan.

* #### (2) Use of a single card
  * A card that is issued under section 1395w–104(b)(2)(A) of this title for use under a part D plan may also be used in connection with coverage of benefits provided under a State Pharmaceutical Assistance Program and, in such case, may contain an emblem or symbol indicating such connection.

* #### (3) Other provisions
  * The provisions of section 1395w–134(c) of this title shall apply to the requirements under this section.

* #### (4) Special treatment under out-of-pocket rule
  * In applying section 1395w–102(b)(4)(C)(ii) of this title, expenses incurred under a State Pharmaceutical Assistance Program may be counted toward the annual out-of-pocket threshold.

* #### (5) Construction
  * Nothing in this section shall be construed as requiring a State Pharmaceutical Assistance Program to coordinate or provide financial assistance with respect to any part D plan.

#### (d) Facilitation of transition and coordination with State Pharmaceutical Assistance Programs
* #### (1) Transitional grant program
  * The Secretary shall provide payments to State Pharmaceutical Assistance Programs with an application approved under this subsection.

* #### (2) Use of funds
  * Payments under this section may be used by a Program for any of the following:

    * (A) Educating part D eligible individuals enrolled in the Program about the prescription drug coverage available through part D plans under this part.

    * (B) Providing technical assistance, phone support, and counseling for such enrollees to facilitate selection and enrollment in such plans.

    * (C) Other activities designed to promote the effective coordination of enrollment, coverage, and payment between such Program and such plans.

* #### (3) Allocation of funds
  * Of the amount appropriated to carry out this subsection for a fiscal year, the Secretary shall allocate payments among Programs that have applications approved under paragraph (4) for such fiscal year in proportion to the number of enrollees enrolled in each such Program as of October 1, 2003.

* #### (4) Application
  * No payments may be made under this subsection except pursuant to an application that is submitted and approved in a time, manner, and form specified by the Secretary.

* #### (5) Funding
  * Out of any funds in the Treasury not otherwise appropriated, there are appropriated for each of fiscal years 2005 and 2006, $62,500,000 to carry out this subsection.

### §1395w–134. Coordination requirements for plans providing prescription drug coverage
#### (a) Application of benefit coordination requirements to additional plans
* #### (1) In general
  * The Secretary shall apply the coordination requirements established under section 1395w–133(a) of this title to Rx plans described in subsection (b) in the same manner as such requirements apply to a State Pharmaceutical Assistance Program.

* #### (2) Application to treatment of certain out-of-pocket expenditures
  * To the extent specified by the Secretary, the requirements referred to in paragraph (1) shall apply to procedures established under section 1395w–102(b)(4)(D) of this title.

* #### (3) User fees
  * #### (A) In general
    * The Secretary may impose user fees for the transmittal of information necessary for benefit coordination under section 1395w–102(b)(4)(D) of this title in a manner similar to the manner in which user fees are imposed under section 1395u(h)(3)(B) of this title, except that the Secretary may retain a portion of such fees to defray the Secretary's costs in carrying out procedures under section 1395w–102(b)(4)(D) of this title.

  * #### (B) Application
    * A user fee may not be imposed under subparagraph (A) with respect to a State Pharmaceutical Assistance Program.

#### (b) Rx Plan
* An Rx plan described in this subsection is any of the following:

* #### (1) Medicaid programs
  * A State plan under subchapter XIX, including such a plan operating under a waiver under section 1315 of this title, if it meets the requirements of section 1395w–133(b)(2) of this title.

* #### (2) Group health plans
  * An employer group health plan.

* #### (3) FEHBP
  * The Federal employees health benefits plan under chapter 89 of title 5.

* #### (4) Military coverage (including TRICARE)
  * Coverage under chapter 55 of title 10.

* #### (5) Other prescription drug coverage
  * Such other health benefit plans or programs that provide coverage or financial assistance for the purchase or provision of prescription drug coverage on behalf of part D eligible individuals as the Secretary may specify.

#### (c) Relation to other provisions
* #### (1) Use of cost management tools
  * The requirements of this section shall not impair or prevent a PDP sponsor or MA organization from applying cost management tools (including differential payments) under all methods of operation.

* #### (2) No affect on treatment of certain out-of-pocket expenditures
  * The requirements of this section shall not affect the application of the procedures established under section 1395w–102(b)(4)(D) of this title.